These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2148935)
21. Inhibition of beta-glucosidase by imidazoles. Li YK; Byers LD Biochim Biophys Acta; 1989 Dec; 999(3):227-32. PubMed ID: 2532549 [TBL] [Abstract][Full Text] [Related]
22. Comparing Cyclophellitol N-Alkyl and N-Acyl Cyclophellitol Aziridines as Activity-Based Glycosidase Probes. Jiang J; Beenakker TJ; Kallemeijn WW; van der Marel GA; van den Elst H; Codée JD; Aerts JM; Overkleeft HS Chemistry; 2015 Jul; 21(30):10861-9. PubMed ID: 26073749 [TBL] [Abstract][Full Text] [Related]
23. Different effects of the glucosidase inhibitors 1-deoxynojirimycin, N-methyl-1-deoxynojirimycin and castanospermine on the glycosylation of rat alpha 1-proteinase inhibitor and alpha 1-acid glycoprotein. Gross V; Tran-Thi TA; Schwarz RT; Elbein AD; Decker K; Heinrich PC Biochem J; 1986 Jun; 236(3):853-60. PubMed ID: 2947571 [TBL] [Abstract][Full Text] [Related]
24. A fluorescence study of isofagomine protonation in β-glucosidase. Lindbäck E; Laursen BW; Poulsen JC; Kilså K; Pedersen CM; Bols M Org Biomol Chem; 2015 Jun; 13(23):6562-6. PubMed ID: 25978843 [TBL] [Abstract][Full Text] [Related]
25. Direct NMR-spectroscopic determination of active-enzyme concentration by titration with a labeled inhibitor: determination of the k(cat) value of almond beta-glucosidase. Hansen SU; Plesner IW; Bols M Chembiochem; 2000 Oct; 1(3):177-80. PubMed ID: 11828410 [TBL] [Abstract][Full Text] [Related]
26. Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease. Glew RH; Daniels LB; Clark LS; Hoyer SW J Neuropathol Exp Neurol; 1982 Nov; 41(6):630-41. PubMed ID: 6813430 [TBL] [Abstract][Full Text] [Related]
27. Slow inhibition of almond beta-glucosidase by azasugars: determination of activation energies for slow binding. Bülow A; Plesner IW; Bols M Biochim Biophys Acta; 2001 Feb; 1545(1-2):207-15. PubMed ID: 11342046 [TBL] [Abstract][Full Text] [Related]
29. 6-Amino-6-deoxy-5,6-di-N-(N'-octyliminomethylidene)nojirimycin: synthesis, biological evaluation, and crystal structure in complex with acid beta-glucosidase. Brumshtein B; Aguilar-Moncayo M; García-Moreno MI; Ortiz Mellet C; García Fernández JM; Silman I; Shaaltiel Y; Aviezer D; Sussman JL; Futerman AH Chembiochem; 2009 Jun; 10(9):1480-5. PubMed ID: 19437524 [No Abstract] [Full Text] [Related]
30. Cell type dependent inhibition of transport of cathepsin D in HepG2 cells and fibroblasts exposed to deoxy-manno-nojirimycin and deoxynojirimycin. Nauerth A; Lemansky P; Hasilik A; von Figura K; Bause E; Legler G Biol Chem Hoppe Seyler; 1985 Nov; 366(11):1009-16. PubMed ID: 2934077 [TBL] [Abstract][Full Text] [Related]
31. Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases. Asano N; Nishida M; Kato A; Kizu H; Matsui K; Shimada Y; Itoh T; Baba M; Watson AA; Nash RJ; Lilley PM; Watkin DJ; Fleet GW J Med Chem; 1998 Jul; 41(14):2565-71. PubMed ID: 9651160 [TBL] [Abstract][Full Text] [Related]
32. Study of beta-glucosidase from Helix pomatia by active site-directed inhibitors. Donsimoni R; Legler G; Bourbouze R; Lalegerie P Enzyme; 1988; 39(2):78-89. PubMed ID: 2969330 [TBL] [Abstract][Full Text] [Related]
33. Investigation of the slow inhibition of almond beta-glucosidase and yeast isomaltase by 1-azasugar inhibitors: evidence for the 'direct binding' model. Lohse A; Hardlei T; Jensen A; Plesner IW; Bols M Biochem J; 2000 Jul; 349(Pt 1):211-5. PubMed ID: 10861230 [TBL] [Abstract][Full Text] [Related]
34. Human acid beta-glucosidase: use of inhibitors, alternative substrates and amphiphiles to investigate the properties of the normal and Gaucher disease active sites. Osiecki-Newman K; Fabbro D; Legler G; Desnick RJ; Grabowski GA Biochim Biophys Acta; 1987 Sep; 915(1):87-100. PubMed ID: 2956992 [TBL] [Abstract][Full Text] [Related]
35. Alpha-1-C-octyl-1-deoxynojirimycin as a pharmacological chaperone for Gaucher disease. Yu L; Ikeda K; Kato A; Adachi I; Godin G; Compain P; Martin O; Asano N Bioorg Med Chem; 2006 Dec; 14(23):7736-44. PubMed ID: 16919960 [TBL] [Abstract][Full Text] [Related]
36. Activity-Based Probes for Glycosidases: Profiling and Other Applications. Kuo CL; van Meel E; Kytidou K; Kallemeijn WW; Witte M; Overkleeft HS; Artola ME; Aerts JM Methods Enzymol; 2018; 598():217-235. PubMed ID: 29306436 [TBL] [Abstract][Full Text] [Related]
37. A short synthesis of (+)-cyclophellitol. Hansen FG; Bundgaard E; Madsen R J Org Chem; 2005 Nov; 70(24):10139-42. PubMed ID: 16292857 [TBL] [Abstract][Full Text] [Related]
38. Functionalized Cyclophellitols Are Selective Glucocerebrosidase Inhibitors and Induce a Bona Fide Neuropathic Gaucher Model in Zebrafish. Artola M; Kuo CL; Lelieveld LT; Rowland RJ; van der Marel GA; Codée JDC; Boot RG; Davies GJ; Aerts JMFG; Overkleeft HS J Am Chem Soc; 2019 Mar; 141(10):4214-4218. PubMed ID: 30811188 [TBL] [Abstract][Full Text] [Related]
39. The alpha-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth. Pili R; Chang J; Partis RA; Mueller RA; Chrest FJ; Passaniti A Cancer Res; 1995 Jul; 55(13):2920-6. PubMed ID: 7540952 [TBL] [Abstract][Full Text] [Related]
40. The structural basis of the inhibition of human glycosidases by castanospermine analogues. Winchester BG; Cenci di Bello I; Richardson AC; Nash RJ; Fellows LE; Ramsden NG; Fleet G Biochem J; 1990 Jul; 269(1):227-31. PubMed ID: 2115770 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]